Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Mania Ackermann, Henning Kempf, Miriam Hetzel, Christina Hesse, Anna Rafiei Hashtchin, Kerstin Brinkert, Juliane Wilhelmine Schott, Kathrin Haake, Mark Philipp Kühnel, Silke Glage, Constanca Figueiredo, Danny Jonigk, Katherina Sewald, Axel Schambach, Sabine Wronski, Thomas Moritz, Ulrich Martin, Robert Zweigerdt, Antje Munder, Nico Lachmann

Journal title: Nature Communications

Journal number: 9/1

Journal publisher: Nature Publishing Group

Published year: 2018

DOI identifier: 10.1038/s41467-018-07570-7

ISSN: 2041-1723